United Therapeutics reported $17.9B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Ardelyx USD 1.51B 568M Sep/2025
Baxter International USD 15.54B 2.02B Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
Insmed USD 19.09B 5.22B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Moderna USD 10.67B 290M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
PTC Therapeutics USD 3.87B 148M Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
Teva Pharmaceutical Industries ILS 65.36B 1.34B Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025